We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+33.56%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$4.36B
AUM Growth
+$1.18B
Cap. Flow
+$206M
Cap. Flow %
4.73%
Top 10 Hldgs %
59.63%
Holding
58
New
13
Increased
19
Reduced
21
Closed
2

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$59.8M
2
ELV icon
Elevance Health
ELV
+$56.6M
3
LYFT icon
Lyft
LYFT
+$50.4M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$41.3M
5
BAX icon
Baxter International
BAX
+$33.8M

Top Sells

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$67.3M
2
HCA icon
HCA Healthcare
HCA
+$49.5M
3
THC icon
Tenet Healthcare
THC
+$48.5M
4
HOLX
Hologic
HOLX
+$45.6M
5
MTOR
MERITOR, Inc.
MTOR
+$29.4M

Sector Composition

Rank Sector Weight
1 Healthcare 69.28%
2 Technology 11.97%
3 Materials 5.01%
4 Consumer Discretionary 4.95%
5 Industrials 3.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
1
Tenet Healthcare
THC
$21.1B
$729M 16.72%
18,258,810
-1,502,543
-8% -$48.5M
BHC icon
2
Bausch Health
BHC
$2.34B
$342M 7.84%
16,434,019
+1,476,311
+10% +$27.5M
TAK icon
3
Takeda Pharmaceutical
TAK
$55.7B
$278M 6.37%
15,260,512
-1,528,077
-9% -$26.8M
DXC icon
4
DXC Technology
DXC
$1.73B
$261M 5.99%
10,149,059
-69,156
-0.7% -$1.48M
CI icon
5
Cigna
CI
$74.6B
$261M 5.99%
1,255,021
-55,006
-4% -$10.8M
HCA icon
6
HCA Healthcare
HCA
$89.5B
$214M 4.9%
1,300,181
-338,334
-21% -$49.5M
MCK icon
7
McKesson
MCK
$101B
$203M 4.66%
1,167,689
-99,570
-8% -$16.6M
LH icon
8
Labcorp
LH
$25.9B
$112M 2.58%
642,746
-170,240
-21% -$29.4M
LYFT icon
9
Lyft
LYFT
$6.63B
$101M 2.33%
2,064,179
+1,385,227
+204% +$50.4M
NUAN
10
DELISTED
Nuance Communications, Inc.
NUAN
$98.7M 2.26%
2,238,367
-167,900
-7% -$6.36M
BSX icon
11
Boston Scientific
BSX
$71.5B
$97.2M 2.23%
2,702,881
+1,657,829
+159% +$59.8M
UHS icon
12
Universal Health Services
UHS
$10.5B
$85.8M 1.97%
624,152
+48,518
+8% +$6.04M
COR icon
13
Cencora
COR
$61.2B
$85.6M 1.96%
875,442
+55,768
+7% +$5.58M
FMC icon
14
FMC
FMC
$1.33B
$81.8M 1.88%
711,796
+17,287
+2% +$1.92M
BKD icon
15
Brookdale Senior Living
BKD
$3.4B
$79.8M 1.83%
18,005,910
+5,419,356
+43% +$20M
MTOR
16
DELISTED
MERITOR, Inc.
MTOR
$77M 1.76%
2,757,332
-1,113,959
-29% -$29.4M
MYGN icon
17
Myriad Genetics
MYGN
$312M
$72.8M 1.67%
3,682,691
+924,698
+34% +$14.9M
ESI icon
18
Element Solutions
ESI
$9.23B
$68.6M 1.57%
3,866,712
+1,383,189
+56% +$19.1M
HUM icon
19
Humana
HUM
$46.2B
$65.4M 1.5%
159,480
+76,391
+92% +$31.8M
CAR icon
20
Avis
CAR
$5.02B
$64.3M 1.47%
1,724,413
+403,059
+31% +$14.2M
IQV icon
21
IQVIA
IQV
$39.3B
$60.9M 1.4%
339,657
-79,328
-19% -$13.4M
ELV icon
22
Elevance Health
ELV
$85.5B
$59.2M 1.36%
+184,461
New +$56.6M
HOLX
23
DELISTED
Hologic
HOLX
$58.6M 1.34%
804,442
-645,729
-45% -$45.6M
EXPE icon
24
Expedia Group
EXPE
$37.3B
$56.8M 1.3%
428,895
+83,462
+24% +$9.41M
FISV
25
Fiserv Inc
FISV
$27.9B
$55.1M 1.26%
483,726
+289,811
+149% +$31.2M
1
2 3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return

Glenview Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Glenview Capital Management held 58 positions worth $4.36B, up 37% from $3.19B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Glenview Capital Management deployed $206M of net new capital in Q4 2020, opening 13 new positions and adding to 19 existing holdings. Its largest new stake was Elevance Health: 184,461 shares worth $59.2M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 74% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Paramount Global Class B, an estimated $67.3M trimmed.

  • Glenview Capital Management's largest Q4 2020 buy was Elevance Health: 184,461 shares worth $59.2M.
  • Glenview Capital Management added most to Boston Scientific in Q4 2020, an estimated $59.8M increase.
  • Glenview Capital Management's biggest Q4 2020 reduction was Paramount Global Class B, cutting an estimated $67.3M.
  • Glenview Capital Management fully exited eBay in Q4 2020, selling an estimated $15.1M.
  • Glenview Capital Management's ten largest holdings make up 60% of its $4.36B portfolio in Q4 2020.
  • Glenview Capital Management opened 13 new positions and closed 2 in Q4 2020.
  • Glenview Capital Management's portfolio value rose 37% quarter-over-quarter to $4.36B.

Based on Glenview Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.